Hotline:
+ 49 (0) 2204 2918806
Life Sciences
Biological science comprises the whole spectrum of medical research. It includes pharmacy, health care, medical devices and diagnostics. Due to its many direct and indirect impacts, an increased focus has shifted to biotechnology during the last couple of years. Many biotech companies have developed into pharmaceutical and bio-pharmaceutical giants. The biological branch plays an important role for the majority of our society and therefore proved to be an area of particular commercial success. This also explains the strong interest in information potentially providing a strategic market advantage. This category offers diverse information on topics such as digital radiography, laboratory diagnostics, haematology, oncology etc.
Subscribe to RSS Feed

Market studies for category Life Sciences

Items 1 to 10 of 6354 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 636
  1. Net price*
    Year
  2. $9,995.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

    GlobalData
    305 pages
    The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as - - Takeda’s alpha4beta7 inhibitor, Entyvio (vedolizumab)- Johnson & Johnson’s (J&J’s) interleukin (IL)-12/23 inhibitor, Stelara (ustekinumab)These compounds will challenge the current biologics in an attempt to dislod
    Englisch | Zukunftsanalyse | SKU: 402240
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Population Genetics Technologies Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 pages
    Population Genetics Technologies Limited (PGT) is a biotechnology company. The company develops and provides testing of hypotheses on contiguous and non-contiguous regions of the genome. It concentrates on three application areas, such as agricultural biotechnology, infectious disease and cancer diagnostics. The company operates through i
    Englisch | Zukunftsanalyse | SKU: 331542
  4. $3,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    EU5 Orthopedic Prosthetics Market Outlook to 2021

    GlobalData
    189 pages
    GlobalData’s new report, "EU5 Orthopedic Prosthetics Market Outlook to 2021", provides key market data on the EU5 Orthopedic Prosthetics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Lower Extremity Prosthetics and Upper Extremity Pros
    Englisch | Marktstudie | SKU: 987689596
  5. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Moberg Pharma AB (MOB) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 pages
    Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. It specializes in developing and commercializing medical products for the treatment of skin diseases, including dry skin and bacterial and fungal infections. Moberg Derma’s products include Emtrix/Nalox for the treatment of discolored and deformed n
    Englisch | Zukunftsanalyse | SKU: 300701
  6. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Germany Peripheral Vascular Devices Market Outlook to 2020

    GlobalData
    115 pages
    GlobalData’s new report, "Germany Peripheral Vascular Devices Market Outlook to 2020", provides key market data on the Germany Peripheral Vascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Inferior Vena Cava Filters (IVCF
    Englisch | Zukunftsanalyse | SKU: 403180
  7. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of ZIOPHARM Oncology, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The prof
    Englisch | Zukunftsanalyse | SKU: 84743
  8. $1,000.00
    Für diese Studie liegt keine Bewertung vor.

    Abbott Laboratories Market Share Analysis

    GlobalData
    193 pages
    Introduction GlobalData’s medical devices report, “Abbott Laboratories Market Share Analysis” provides in-depth information on Abbott’s market position in the different medical equipment markets it operates in. The report provides Abbott’s market share information in nine key market categories – Clinical Chemistry, Genetic Te
    Englisch | Marktstudie | SKU: 111131
  9. $3,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    EU5 Hip Reconstruction Market Outlook to 2020

    GlobalData
    162 pages
    GlobalData’s new report, "EU5 Hip Reconstruction Market Outlook to 2020", provides key market data on the EU5 Hip Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories – Hip Resurfacing, Partial Hip Replacement, Primary Hip Re
    Englisch | Zukunftsanalyse | SKU: 401884
  10. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013

    GlobalData
    113 pages
    Introduction GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis.
    Englisch | Report | SKU: 330301
  11. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Uveal Melanoma Global Clinical Trials Review, H1, 2015

    GlobalData
    70 pages
    GlobalData's clinical trial report, “Uveal Melanoma Global Clinical Trials Review, H1, 2015" provides data on the Uveal Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uveal Melanoma. It includes an overview of the trial numbers and their recruitment status as per
    Englisch | Zukunftsanalyse | SKU: 987680111

Items 1 to 10 of 6354 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 636